\
&
Contact us
Published on | 2 years ago
Programmes Enhancing EU R&IThis report presents the findings of the European Commission’s Expert Group on the COVID-19 impact on gender equality in Research and Innovation (R&I). The report highlights in particular the pandemic’s gendered impact on academic productivity, early career researchers (ECRs), and work-life balance. It investigates institutional responses and aims to bring forward unseen and marginalised experiences in academia. The recommendations are intended for R&I policymakers at national and EU-level, research funding organisations and research performing organisations. They present an opportunity for Member States and R&I organisations to apply the lessons learnt from the pandemic to the development of inclusive gender equality policies in the European Research Area (ERA). (from the report’s back cover)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.